This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murakami, E.
Right arrow Articles by Furman, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murakami, E.
Right arrow Articles by Furman, P. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2008, p. 458-464, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.01184-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Mechanism of Action of β-D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine Involves a Second Metabolic Pathway Leading to β-D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine 5'-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase{triangledown}

Eisuke Murakami, Congrong Niu, Haiying Bao, Holly M. Micolochick Steuer, Tony Whitaker,{dagger} Tammy Nachman, Michael A. Sofia, Peiyuan Wang, Michael J. Otto, and Phillip A. Furman*

Pharmasset, Inc., 303 A College Road East, Princeton, New Jersey 08540

Received 7 September 2007/ Returned for modification 12 October 2007/ Accepted 30 October 2007

β-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) is a potent inhibitor of hepatitis C virus (HCV) RNA replication in an HCV replicon assay. The 5'-triphosphate of PSI-6130 is a competitive inhibitor of the HCV RNA-dependent RNA polymerase (RdRp) and acts as a nonobligate chain terminator. Recently, it has been shown that the metabolism of PSI-6130 also results in the formation of the 5'-triphosphate of the uridine congener, β-D-2'-deoxy-2'-fluoro-2'-C-methyluridine (PSI-6206; RO2433). Here we show that the formation of the 5'-triphosphate of RO2433 (RO2433-TP) requires the deamination of PSI-6130 monophosphate and that RO2433 monophosphate is subsequently phosphorylated to the corresponding di- and triphosphates by cellular UMP-CMP kinase and nucleoside diphosphate kinase, respectively. RO2433-TP is a potent inhibitor of the HCV RdRp; however, both enzymatic and cell-based assays show that PSI-6130 triphosphate is a more potent inhibitor of the HCV RdRp than RO2433-TP.


* Corresponding author. Mailing address: Pharmasset, Inc., 303 A College Road East, Princeton, NJ 08540. Phone: (609) 613-4100. Fax: (609) 613-4150. E-mail: phillip.furman{at}pharmasset.com

{triangledown} Published ahead of print on 12 November 2007.

{dagger} Present address: RFS Pharma LLC, 1860 Montreal Road, Tucker, GA 30084.


Antimicrobial Agents and Chemotherapy, February 2008, p. 458-464, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.01184-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ali, S., Leveque, V., Le Pogam, S., Ma, H., Philipp, F., Inocencio, N., Smith, M., Alker, A., Kang, H., Najera, I., Klumpp, K., Symons, J., Cammack, N., Jiang, W.-R. (2008). Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479. Antimicrob. Agents Chemother. 52: 4356-4369 [Abstract] [Full Text]